One of India's biggest drug makers, Ranbaxy Laboratories, revealed that it has initiated a recall of its cholesterol-lowering drug Atorvastatin calcium in the United States after finding that some of the batches may contain small amounts of glass. The company said that the recall could lead to temporary disruption in supply of the drug as it may take up to two weeks for it to complete an investigation. Analysts are also predicting that the recall will hurt ...
via Medindia Health News More READ
No comments:
Post a Comment